ClinVar Genomic variation as it relates to human health
NM_000243.3(MEFV):c.2040G>C (p.Met680Ile)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000243.3(MEFV):c.2040G>C (p.Met680Ile)
Variation ID: 36507 Accession: VCV000036507.104
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 16p13.3 16: 3243447 (GRCh38) [ NCBI UCSC ] 16: 3293447 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Apr 4, 2013 Oct 20, 2024 Aug 1, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000243.3:c.2040G>C MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000234.1:p.Met680Ile missense NM_001198536.2:c.*244G>C 3 prime UTR NC_000016.10:g.3243447C>G NC_000016.9:g.3293447C>G NG_007871.1:g.18181G>C LRG_190:g.18181G>C LRG_190t1:c.2040G>C LRG_190p1:p.Met680Ile O15553:p.Met680Ile - Protein change
- -
- Other names
-
MEFV, MET680ILE, 2040G-C
M680I
- Canonical SPDI
- NC_000016.10:3243446:C:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
Trans-Omics for Precision Medicine (TOPMed) 0.00006
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MEFV | No evidence available | No evidence available |
GRCh38 GRCh37 |
960 | 1261 | |
LOC126862264 | - | - | - | GRCh38 | - | 257 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (14) |
criteria provided, multiple submitters, no conflicts
|
Jan 22, 2024 | RCV000030179.35 | |
Pathogenic (16) |
criteria provided, multiple submitters, no conflicts
|
Aug 1, 2024 | RCV000222364.67 | |
Pathogenic (1) |
criteria provided, single submitter
|
Feb 25, 2020 | RCV001197705.10 | |
no classifications from unflagged records (1) |
no classifications from unflagged records
|
- | RCV000515335.15 | |
See cases
|
Pathogenic (1) |
criteria provided, single submitter
|
Apr 6, 2021 | RCV002251932.9 |
Pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Mar 26, 2024 | RCV002254152.11 | |
Pathogenic (1) |
criteria provided, single submitter
|
Jan 11, 2018 | RCV002415433.9 | |
Pathogenic (1) |
criteria provided, single submitter
|
Apr 8, 2022 | RCV002477026.8 | |
Pathogenic (1) |
criteria provided, single submitter
|
Feb 8, 2022 | RCV002262586.10 | |
MEFV-related disorder
|
Pathogenic (1) |
no assertion criteria provided
|
Mar 6, 2024 | RCV004739312.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
pathogenic
(Aug 18, 2011)
|
criteria provided, single submitter
Method: curation, clinical testing
|
Familial Mediterranean Fever
(autosomal recessive)
Affected status: unknown, yes
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV000052839.2
First in ClinVar: Apr 04, 2013 Last updated: Apr 11, 2022 |
Comment:
Converted during submission to Pathogenic.
Observation 1:
Number of individuals with the variant: 2
Observation 2:
Number of individuals with the variant: 13
Observation 3:
Number of individuals with the variant: 2
Observation 4:
Number of individuals with the variant: 24
Observation 5:
Tissue: Blood
Observation 6:
Tissue: Blood
Observation 7:
Tissue: Blood
Observation 8:
Tissue: Blood
Observation 9:
Tissue: Blood
Observation 10:
Tissue: Blood
Observation 11:
Tissue: Blood
|
|
Pathogenic
(Oct 14, 2014)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Eurofins Ntd Llc (ga)
Accession: SCV000224797.5
First in ClinVar: Jun 28, 2015 Last updated: Dec 15, 2018 |
Number of individuals with the variant: 1
Sex: mixed
|
|
Pathogenic
(Oct 23, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
(Autosomal unknown)
Affected status: yes
Allele origin:
germline
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Accession: SCV001447340.1
First in ClinVar: Nov 28, 2020 Last updated: Nov 28, 2020 |
Clinical Features:
Fever (present) , Recurrent fever (present) , Episodic abdominal pain (present)
Sex: male
|
|
Pathogenic
(Feb 20, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Quest Diagnostics Nichols Institute San Juan Capistrano
Accession: SCV001134279.3
First in ClinVar: Jan 06, 2020 Last updated: Jan 03, 2022 |
Comment:
The best available variant frequency is uninformative. Found in at least one symptomatic patient. Predicted to have a tolerated effect on the protein. One other … (more)
The best available variant frequency is uninformative. Found in at least one symptomatic patient. Predicted to have a tolerated effect on the protein. One other pathogenic or likely pathogenic variant affects the same amino acid. Occurs in multiple cases with a recessive pathogenic variant in the same gene. Assessment of experimental evidence suggests this variant results in abnormal protein function. (less)
|
|
Pathogenic
(Jul 18, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever
Affected status: yes
Allele origin:
germline
|
Laboratory of Medical Genetics, National & Kapodistrian University of Athens
Accession: SCV002577425.1
First in ClinVar: Oct 08, 2022 Last updated: Oct 08, 2022 |
Comment:
PS1, PS3, PM1, PM5, PM2, PP5, BP4
|
|
Pathogenic
(Jun 07, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever
Affected status: yes
Allele origin:
germline
|
MGZ Medical Genetics Center
Accession: SCV002580913.1
First in ClinVar: Oct 15, 2022 Last updated: Oct 15, 2022
Comment:
ACMG criteria applied: PS4, PM3_STR, PS3_MOD, PM1, PP1
|
Number of individuals with the variant: 3
Sex: female
|
|
Pathogenic
(Sep 06, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000279057.13
First in ClinVar: May 29, 2016 Last updated: Mar 04, 2023 |
Comment:
Accounts for approximately 9% of identifiable pathogenic MEFV variants in patients of different ethnic groups (Aksentijevich et al., 1999); In silico analysis supports that this … (more)
Accounts for approximately 9% of identifiable pathogenic MEFV variants in patients of different ethnic groups (Aksentijevich et al., 1999); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 20483145, 27621632, 19967574, 10447272, 16179998, 24433404, 16785446, 30513227, 27457448, 29080837, 19302049, 33440462, 10852276, 20669279, 23973724, 20437121, 21623663, 9288758, 19863562, 24141617, 10364520, 10090880, 23907647, 27513391, 12908875, 19151977, 26510601, 28492532, 29543225, 30783801, 32199921, 34426522, 31589614, 11977178, 32441320, 10662876) (less)
|
|
Pathogenic
(Jan 22, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000629033.9
First in ClinVar: Dec 26, 2017 Last updated: Feb 20, 2024 |
Comment:
This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 680 of the MEFV protein (p.Met680Ile). … (more)
This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 680 of the MEFV protein (p.Met680Ile). This variant is present in population databases (rs28940580, gnomAD 0.02%). This missense change has been observed in individual(s) with symptoms of familial Mediterranean fever (PMID: 9288758, 21623663, 23907647, 23973724). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 36507). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
Pathogenic
(Mar 26, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever, autosomal dominant
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV004194411.2
First in ClinVar: Dec 30, 2023 Last updated: Jun 17, 2024 |
|
|
Pathogenic
(Aug 01, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV001245671.26
First in ClinVar: May 12, 2020 Last updated: Oct 20, 2024 |
Comment:
MEFV: PM3:Very Strong, PS1, PM5, PM2:Supporting, PS3:Supporting, BP4
Number of individuals with the variant: 51
|
|
Pathogenic
(Oct 01, 2014)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics and Genomics, Karolinska University Hospital
Accession: SCV001449578.1
First in ClinVar: Dec 12, 2020 Last updated: Dec 12, 2020 |
Number of individuals with the variant: 31
|
|
Pathogenic
(Feb 25, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Acute febrile neutrophilic dermatosis
Affected status: yes
Allele origin:
unknown
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Accession: SCV001368484.2
First in ClinVar: Jul 06, 2020 Last updated: Jul 06, 2020 |
Comment:
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PM1,PM3,PM5.
|
|
Pathogenic
(Jul 22, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV001810498.1
First in ClinVar: Sep 08, 2021 Last updated: Sep 08, 2021 |
Sex: mixed
|
|
Pathogenic
(Aug 12, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever
Affected status: yes
Allele origin:
germline
|
Centogene AG - the Rare Disease Company
Accession: SCV002059616.1
First in ClinVar: Jan 15, 2022 Last updated: Jan 15, 2022 |
|
|
Pathogenic
(Apr 06, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
See cases
Affected status: yes
Allele origin:
germline
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Accession: SCV002523125.1
First in ClinVar: Jun 11, 2022 Last updated: Jun 11, 2022 |
Comment:
ACMG classification criteria: PS3, PS4, PM2, PM3, BP4
Clinical Features:
Inflammation of the large intestine (present) , Failure to thrive (present) , Bloody diarrhea (present) , Anemia (present) , Abdominal pain (present)
|
|
Pathogenic
(Jun 09, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever, autosomal dominant
(Autosomal dominant inheritance)
Affected status: unknown
Allele origin:
germline
|
Department of Human Genetics, Hannover Medical School
Accession: SCV002525496.1
First in ClinVar: Jun 11, 2022 Last updated: Jun 11, 2022 |
Clinical Features:
Fever (present)
|
|
Pathogenic
(Feb 08, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Autoinflammatory syndrome
Affected status: yes
Allele origin:
germline
|
Genome Diagnostics Laboratory, The Hospital for Sick Children
Accession: SCV002543729.1
First in ClinVar: Jul 09, 2022 Last updated: Jul 09, 2022 |
|
|
Pathogenic
(Apr 08, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever, autosomal dominant
Familial Mediterranean fever Acute febrile neutrophilic dermatosis
Affected status: unknown
Allele origin:
unknown
|
Fulgent Genetics, Fulgent Genetics
Accession: SCV000611205.2
First in ClinVar: Nov 11, 2017 Last updated: Dec 31, 2022 |
|
|
Pathogenic
(Dec 17, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Accession: SCV002818117.1
First in ClinVar: Jan 07, 2023 Last updated: Jan 07, 2023 |
|
|
Pathogenic
(Sep 14, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Accession: SCV000604173.7
First in ClinVar: Sep 30, 2017 Last updated: Mar 04, 2023 |
Comment:
The MEFV c.2040G>C; p.Met680Ile variant (rs28940580) has been published as a common familial Mediterranean fever pathogenic variant (Moradian 2014, The International FMF Consortium 1997). This … (more)
The MEFV c.2040G>C; p.Met680Ile variant (rs28940580) has been published as a common familial Mediterranean fever pathogenic variant (Moradian 2014, The International FMF Consortium 1997). This variant is also reported as pathogenic by multiple laboratories in ClinVar (Variation ID: 36507). It is found in the general population with an overall allele frequency of 0.01% (26/251474 alleles) in the Genome Aggregation Database. Based on available information, this variant is considered to be pathogenic. References: Moradian MM et al. Patient management and the association of less common familial Mediterranean fever symptoms with other disorders. Genet Med. 2014; 16(3):258-63. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997; 90:797-807. (less)
|
|
Pathogenic
(Jul 18, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever
(Autosomal recessive inheritance)
Affected status: no
Allele origin:
unknown
|
Intergen, Intergen Genetics and Rare Diseases Diagnosis Center
Accession: SCV004013446.1
First in ClinVar: Jul 22, 2023 Last updated: Jul 22, 2023 |
|
|
Pathogenic
(Jun 14, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: unknown
Allele origin:
germline
|
Mayo Clinic Laboratories, Mayo Clinic
Accession: SCV004226903.1
First in ClinVar: Jan 06, 2024 Last updated: Jan 06, 2024 |
Comment:
PM1, PS3, PS4
Number of individuals with the variant: 2
|
|
Pathogenic
(Oct 16, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002024334.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Nov 03, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever
Affected status: unknown
Allele origin:
germline
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Accession: SCV004847543.1
First in ClinVar: Apr 20, 2024 Last updated: Apr 20, 2024 |
Comment:
The p.Met680Ile variant in MEFV has been reported in the homozygous and compound heterozygous state in numerous individuals with familial Mediterranean fever and accounts for … (more)
The p.Met680Ile variant in MEFV has been reported in the homozygous and compound heterozygous state in numerous individuals with familial Mediterranean fever and accounts for approximately 9% of pathogenic MEFV variants in individuals of different ethnic groups (example: Aksentijevich 1999 PMID: 10090880). It has been reported in ClinVar (Variation ID 36507) and has been identified in 6/68036 European chromosomes by gnomAD ((http://gnomad.broadinstitute.org). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive familial Mediterranean fever. ACMG/AMP Criteria applied: PM2_Supporting, PM3_VeryStrong, PP1_Strong. (less)
|
|
Pathogenic
(Jan 11, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Inborn genetic diseases
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002723049.2
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
The p.M680I pathogenic mutation (also known as c.2040G>C), located in coding exon 10 of the MEFV gene, results from a G to C substitution at … (more)
The p.M680I pathogenic mutation (also known as c.2040G>C), located in coding exon 10 of the MEFV gene, results from a G to C substitution at nucleotide position 2040. The methionine at codon 680 is replaced by isoleucine, an amino acid with highly similar properties. This mutation is well documented as one of the five most common MEFV mutations and has been seen in both the homozygous and heterozygous states in multiple individuals with a clinical diagnosis of familial Mediterranean fever (FMF). In addition, codon 680 in the MEFV gene has been documented as a mutational hotspot and is associated with severe manifestations of FMF (Neocleous V et al. Ann. Hum. Genet., 2015 Jan;79:20-7; Touitou I. Eur. J. Hum. Genet., 2001 Jul;9:473-83; The International FMF Consortium. Cell, 1997 Aug;90:797-807). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. (less)
|
|
Pathogenic
(Oct 06, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics Laboratory, Skane University Hospital Lund
Accession: SCV005198751.1
First in ClinVar: Aug 25, 2024 Last updated: Aug 25, 2024 |
|
|
Pathogenic
(Apr 01, 1999)
|
no assertion criteria provided
Method: literature only
|
FAMILIAL MEDITERRANEAN FEVER
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000022808.2
First in ClinVar: Apr 04, 2013 Last updated: Jun 15, 2020 |
Comment on evidence:
In the affected offspring of a single Armenian family with familial Mediterranean fever (FMF; 249100), the International FMF Consortium (1997) found homozygosity for a 2040G-C … (more)
In the affected offspring of a single Armenian family with familial Mediterranean fever (FMF; 249100), the International FMF Consortium (1997) found homozygosity for a 2040G-C transversion that resulted in a met680-to-ile (M680I) amino acid substitution in the pyrin protein. In Turkish and Armenian FMF patients with the ARM2 haplotype, the French FMF Consortium (1997) likewise found this G-C transversion at nucleotide 1130 of their partial cDNA sequence of the MEFV gene. Aksentijevich et al. (1999) found that the same amino acid change was produced by a 2040G-A transition; see 608107.0013. (less)
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Genome Diagnostics Laboratory, University Medical Center Utrecht
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001930242.1 First in ClinVar: Sep 26, 2021 Last updated: Sep 26, 2021 |
|
|
Pathogenic
(Mar 06, 2024)
|
no assertion criteria provided
Method: clinical testing
|
MEFV-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV005347588.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024 |
Comment:
The MEFV c.2040G>C variant is predicted to result in the amino acid substitution p.Met680Ile. This variant, in the homozygous, compound heterozygous and heterozygous states, has … (more)
The MEFV c.2040G>C variant is predicted to result in the amino acid substitution p.Met680Ile. This variant, in the homozygous, compound heterozygous and heterozygous states, has been reported to be causative for familial Mediterranean fever (Int. FMF. et al. 1997. PubMed ID: 9288758; Moradian et al. 2014. PubMed ID: 23907647). This variant is reported in 0.023% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. (less)
|
|
Pathogenic
(Mar 15, 2019)
|
no assertion criteria provided
Method: clinical testing
|
Familial Mediterranean fever
Affected status: unknown
Allele origin:
unknown
|
Counsyl
Accession: SCV001132428.1
First in ClinVar: Dec 23, 2019 Last updated: Dec 23, 2019 |
|
|
Pathogenic
(Sep 16, 2020)
|
no assertion criteria provided
Method: clinical testing
|
Familial Mediterranean fever
Affected status: unknown
Allele origin:
germline
|
Natera, Inc.
Accession: SCV001462099.1
First in ClinVar: Jan 02, 2021 Last updated: Jan 02, 2021 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Study: VKGL Data-share Consensus
Accession: SCV001807652.1 First in ClinVar: Aug 27, 2021 Last updated: Aug 27, 2021 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001741393.3 First in ClinVar: Jul 07, 2021 Last updated: Sep 08, 2021 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001959280.1 First in ClinVar: Oct 02, 2021 Last updated: Oct 02, 2021 |
|
|
Pathogenic
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001973052.1 First in ClinVar: Oct 08, 2021 Last updated: Oct 08, 2021 |
|
|
Pathogenic
(May 01, 2022)
|
no assertion criteria provided
Method: clinical testing
|
Familial Mediterranean fever
Affected status: yes
Allele origin:
germline
|
Clinic of Clinical Immunology with Stem Cell Bank, Expert Centre for Rare Diseases - PID, University Hospital "Alexandrovska"
Accession: SCV002573424.1
First in ClinVar: Sep 17, 2022 Last updated: Sep 17, 2022 |
|
|
Pathogenic
(Nov 02, 2023)
|
no assertion criteria provided
Method: clinical testing
|
Familial Mediterranean fever
Affected status: yes
Allele origin:
germline
|
Zotz-Klimas Genetics Lab, MVZ Zotz Klimas
Accession: SCV004101055.1
First in ClinVar: Nov 11, 2023 Last updated: Nov 11, 2023 |
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Familial Mediterranean fever
Affected status: yes
Allele origin:
germline
|
GeneReviews
Accession: SCV000484965.2
First in ClinVar: Jun 28, 2015 Last updated: Oct 01, 2022 |
|
|
Pathogenic
(Oct 04, 2020)
|
Flagged submission
flagged submission
Method: clinical testing
Reason: This record appears to be redundant with a more recent record from the same submitter.
Notes: SCV001448269 appears to be redundant with SCV002818117.
(less)
Notes: SCV001448269 appears to
(...more)
Source: NCBI
|
Familial Mediterranean fever, autosomal dominant
Familial Mediterranean fever
Affected status: yes
Allele origin:
germline
|
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Accession: SCV001448269.1
First in ClinVar: Dec 07, 2020 Last updated: Dec 07, 2020 |
Sex: female
|
|
click to load more click to collapse | |||||
Flagged submissions do not contribute to the aggregate classification or review status for the variant. Learn more |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
MEFV mutations in Iranian Azari Turkish patients with Henoch-Schönlein purpura. | Bonyadi M | Turkish journal of medical sciences | 2016 | PMID: 27513391 |
Familial Mediterranean Fever. | Adam MP | - | 2016 | PMID: 20301405 |
[Influence of M680I and M694V mutations on pyrin's domain B30.2 tertiary structure and it's complex formation ability with caspase-1]. | Arakelov GG | Molekuliarnaia biologiia | 2015 | PMID: 26510601 |
Familial Mediterranean fever associated with MEFV mutations in a large cohort of Cypriot patients. | Neocleous V | Annals of human genetics | 2015 | PMID: 25393764 |
Patient management and the association of less common familial Mediterranean fever symptoms with other disorders. | Moradian MM | Genetics in medicine : official journal of the American College of Medical Genetics | 2014 | PMID: 23907647 |
Common MEFV gene mutations in Turkish patients with Behcet's disease. | Tasliyurt T | Gene | 2013 | PMID: 23973724 |
Common MEFV mutations in Iranian Azeri Turkish patients with Behçet's disease. | Esmaeili M | Scandinavian journal of rheumatology | 2011 | PMID: 21623663 |
Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1β activation and severe autoinflammation in mice. | Chae JJ | Immunity | 2011 | PMID: 21600797 |
Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. | Cosan F | Arthritis and rheumatism | 2010 | PMID: 20669279 |
1Novel MEFV transcripts in Familial Mediterranean fever patients and controls. | Medlej-Hashim M | BMC medical genetics | 2010 | PMID: 20534143 |
Evaluation of common mutations in the Mediterranean fever gene in Multiple Sclerosis patients: is it a susceptibility gene? | Unal A | Journal of the neurological sciences | 2010 | PMID: 20483145 |
High frequency of MEFV gene mutations in patients with myeloid neoplasm. | Oktenli C | International journal of hematology | 2010 | PMID: 20437121 |
A case of familial Mediterranean fever associated with compound heterozygosity for the pyrin variant L110P-E148Q/M680I in Japan. | Oshima K | Modern rheumatology | 2010 | PMID: 19967574 |
MEFV mutations in Iranian Azeri Turkish patients with familial Mediterranean fever. | Bonyadi M | Clinical genetics | 2009 | PMID: 19863562 |
Familial Mediterranean fever with chronic ascites: a case report and a review of literature. | Ureten K | Rheumatology international | 2009 | PMID: 19151977 |
MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. | Giaglis S | Clinical genetics | 2007 | PMID: 17489852 |
The fate of 12 recessive mutations in a single village. | Zlotogora J | Annals of human genetics | 2007 | PMID: 17331080 |
The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. | Chae JJ | Proceedings of the National Academy of Sciences of the United States of America | 2006 | PMID: 16785446 |
Familial Mediterranean fever in the Syrian population: gene mutation frequencies, carrier rates and phenotype-genotype correlation. | Mattit H | European journal of medical genetics | 2006 | PMID: 16627024 |
Prevalence and distribution of MEFV mutations among Arabs from the Maghreb patients suffering from familial Mediterranean fever. | Belmahi L | Comptes rendus biologies | 2006 | PMID: 16439335 |
Regular abdominal pain and fever in each menstruation onset: an unusual menses-associated familial Mediterrenean fever attacks and a favor result on colchicine treatment. | Düzgün N | Rheumatology international | 2006 | PMID: 16179998 |
MEFV analysis is of particularly weak diagnostic value for recurrent fevers in Western European Caucasian patients. | Tchernitchko D | Arthritis and rheumatism | 2005 | PMID: 16255051 |
Genetic screening of familial Mediterranean fever mutations in the Palestinian population. | Ayesh SK | Saudi medical journal | 2005 | PMID: 15951859 |
MEFV mutations in familial Mediterranean fever: association of M694V homozygosity with arthritis. | Olgun A | Rheumatology international | 2005 | PMID: 14727057 |
Familial Mediterranean fever, inflammation and nephrotic syndrome: fibrillary glomerulopathy and the M680I missense mutation. | Fisher PW | BMC nephrology | 2003 | PMID: 12908875 |
The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. | Gershoni-Baruch R | Arthritis and rheumatism | 2003 | PMID: 12687559 |
MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study. | Balci B | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2002 | PMID: 12401847 |
Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent inflammatory attacks. | Dodé C | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2002 | PMID: 12105243 |
The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. | Gershoni-Baruch R | European journal of human genetics : EJHG | 2002 | PMID: 11938447 |
The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. | Mansfield E | Blood | 2001 | PMID: 11468188 |
The spectrum of Familial Mediterranean Fever (FMF) mutations. | Touitou I | European journal of human genetics : EJHG | 2001 | PMID: 11464238 |
Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. | Cazeneuve C | American journal of human genetics | 2000 | PMID: 11017802 |
MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? | Tekin M | Clinical genetics | 2000 | PMID: 10905662 |
The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant? | Ben-Chetrit E | Human mutation | 2000 | PMID: 10737995 |
MEFV mutations in Turkish patients suffering from Familial Mediterranean Fever. | Akar N | Human mutation | 2000 | PMID: 10612841 |
Direct detection of common mutations in the familial Mediterranean fever gene (MEFV) using naturally occurring and primer mediated restriction fragment analysis. Mutation in brief no. 257. Online. | Gershoni-Baruch R | Human mutation | 1999 | PMID: 10447272 |
MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. | Cazeneuve C | American journal of human genetics | 1999 | PMID: 10364520 |
Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. | Aksentijevich I | American journal of human genetics | 1999 | PMID: 10090880 |
Pyrin/marenostrin mutations in familial Mediterranean fever. | Booth DR | QJM : monthly journal of the Association of Physicians | 1998 | PMID: 10024914 |
Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. | - | Cell | 1997 | PMID: 9288758 |
A candidate gene for familial Mediterranean fever. | French FMF Consortium | Nature genetics | 1997 | PMID: 9288094 |
http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MEFV | - | - | - | - |
click to load more click to collapse |
Text-mined citations for rs28940580 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.